| 다발성경화증 시장 이해에 관한 연구 |
|
민주홍1,2, 김병준1,2, 김광국3 |
1성균관대학교 의과대학, 삼성서울병원, 신경과학교실
2삼성서울병원, 뇌신경센터
3울산대학교 의과대학, 아산병원, 신경과학교실 |
| Multiple Sclerosis Market Understanding Study |
|
Ju-Hong Min1,2, Byoung Joon Kim1,2, Kwang Kook Kim3 |
1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2Neuroscience Center, Samsung Medical Center, Seoul, Korea
3Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
|
|
| Abstract |
|
"Multiple sclerosis (MS) is a CNS demyelinating disorder, which affects young aged people. In Korea, the prevalence of MS is very lower than that of western countries. Now, more than 10 disease modifyingtherapeutics (DMTs) were discovered; therefore the early diagnosis and treatment optimizationis very important in MS patients. Herein, to understand MS market in Korea, we investigatedthe current diagnostic strategy and therapeutic choice of DMTs by Korean MS specialists inreal world practice. Journal of Multiple Sclerosis 8(2):19-23, 2017" |
| Key Words:
Multiple sclerosis, Disease modifying therapeutic, Korea |
|
PDF Links
Download Citation
